The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business Hims & Hers reported quarterly results Monday after the closing bell. Shares of ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Shares of Hims & Hers fell after hours on Monday after the wellness platform’s first-quarter profit forecast missed expectations, pressured by the money it spent on a Super Bowl ad and planned ...